8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
May 7, 2026·SEC
Material company update
Apr 17, 2026·SEC
Cross Country Healthcare, Inc.(CCRN)Earnings, Financials & Key Ratios
CCRN•NASDAQ
Price updated Jun 17, 2026
AboutCross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.Show more
- Revenue$1.05B-21.6%
- EBITDA$13M+1999.5%
- Net Income-$95M-551.6%
- EPS (Diluted)-2.93-565.9%
- Gross Margin18.66%-8.5%
- EBITDA Margin1.26%+2579.0%
- Operating Margin-0.33%+73.8%
- Net Margin-9%-730.7%
- ROE-25.57%-683.9%
CCRN Key Insights
Cross Country Healthcare, Inc. (CCRN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Momentum leader: RS Rating 87 (top 13%)
- ✓Share count reduced 2.9% through buybacks
- ✓Trading at only 1.3x book value
- ✓Efficient asset utilization: 2.3x turnover
✗Weaknesses
- ✗Profits declining 48.9% over 5 years
- ✗Thin 5Y average net margin of 1.6%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CCRN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CCRN Price & Volume
Cross Country Healthcare, Inc. (CCRN) stock price & volume — 10-year historical chart
Loading chart...
CCRN Growth Metrics
Cross Country Healthcare, Inc. (CCRN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years3.23%
5 Years4.74%
3 Years-27.82%
TTM-20.37%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-456.03%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-472.55%
Return on Capital
10 Years8.8%
5 Years18.82%
3 Years4.83%
Last Year-0.82%
CCRN Recent Earnings
Cross Country Healthcare, Inc. (CCRN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.03+40.0%
$0.05
Rev
$241M+1.7%
$237M
Q2 2026
Mar 4, 2026Metric
Actual
Est
EPS
$0.06-300.0%
$0.03
Rev
$237M-6.9%
$254M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.03-25.0%
$0.04
Rev
$250M-1.7%
$254M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.01-114.3%
$0.07
Rev
$274M-6.7%
$294M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.03vs $0.05+40.0% | $241Mvs $237M+1.7% |
| Q2 2026 | Mar 4, 2026 | $0.06vs $0.03-300.0% | $237Mvs $254M-6.9% |
| Q4 2025 | Nov 12, 2025 | $0.03vs $0.04-25.0% | $250Mvs $254M-1.7% |
| Q3 2025 | Aug 6, 2025 | $0.01vs $0.07-114.3% | $274Mvs $294M-6.7% |
Based on last 12 quarters of dataView full earnings history →
CCRN Peer Comparison
Cross Country Healthcare, Inc. (CCRN) competitors in Healthcare staffing and facility services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 AMN | 1.26B | 32.38 | -13.06 | -8.49% | -0.95% | -4.98% | 1.25 | |
 TBI | 205.54M | 6.77 | -4.21 | 3.1% | -4.29% | -18.74% | 0.62 | |
 HCSG | 1.6B | 22.37 | 27.62 | 7.08% | 3.21% | 11.83% | 0.05 | |
 KELYA | 395.23M | 11.40 | -1.57 | -1.87% | -6.44% | -24.58% | 0.16 | |
 MAN | 1.59B | 34.29 | -118.24 | 0.58% | -0.07% | -0.65% | 1.16 | |
 ASGN | 894.99M | 20.96 | 8.06 | -2.91% | 2.85% | 6.26% | 0.65 | |
 KFY | 3.69B | 71.67 | 15.58 | -1.23% | 9.29% | 13.9% | 0.31 | |
 HIMS | 7B | 31.89 | 62.53 | 59% | -0.56% | -2.48% | 2.34 |
Compare CCRN vs Peers
Cross Country Healthcare, Inc. (CCRN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CCRN Income Statement
Cross Country Healthcare, Inc. (CCRN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 865.05M | 816.48M | 822.22M | 836.42M | 1.68B | 2.8B | 2.02B | 1.34B | 1.05B | 1B |
Revenue Growth % | 3.78% | -5.61% | 0.7% | 1.73% | 100.46% | 67.2% | -27.95% | -33.46% | -21.56% | -20.37% |
Cost of Goods Sold | 636.46M | 606.92M | 618.22M | 633.68M | 1.3B | 2.18B | 1.57B | 1.07B | 857.52M | 803.11M |
COGS % of Revenue | 73.58% | 74.33% | 75.19% | 75.76% | 77.63% | 77.72% | 77.7% | 79.59% | 81.34% | - |
Gross Profit | 228.59M▲ 0% | 209.56M▼ 8.3% | 204.01M▼ 2.7% | 202.73M▼ 0.6% | 375M▲ 85.0% | 624.46M▲ 66.5% | 450.41M▼ 27.9% | 274.25M▼ 39.1% | 196.78M▼ 28.2% | 198.84M▲ 0% |
Gross Margin % | 26.42% | 25.67% | 24.81% | 24.24% | 22.37% | 22.28% | 22.3% | 20.41% | 18.66% | 19.84% |
Gross Profit Growth % | 3.09% | -8.32% | -2.65% | -0.63% | 84.97% | 66.52% | -27.87% | -39.11% | -28.25% | - |
Operating Expenses | 197.61M | 192.01M | 219.72M | 211.89M | 235.69M | 354.58M | 337.7M | 291.12M | 200.24M | 219.72M |
OpEx % of Revenue | 22.84% | 23.52% | 26.72% | 25.33% | 14.06% | 12.65% | 16.72% | 21.66% | 18.99% | - |
Selling, General & Admin | 189.26M | 182.43M | 183.97M | 176.84M | 220.04M | 324.21M | 314.95M | 254.81M | 200.68M | 147.11M |
SG&A % of Revenue | 21.88% | 22.34% | 22.37% | 21.14% | 13.12% | 11.56% | 15.59% | 18.96% | 19.03% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 155K | 418K | 35.75M | 35.05M | 15.65M | 30.37M | 22.74M | 36.31M | -441K | 3.06M |
Operating Income | 11.75M▲ 0% | -12.88M▼ 209.6% | -15.71M▼ 22.0% | -9.16M▲ 41.7% | 139.3M▲ 1620.8% | 269.88M▲ 93.7% | 112.71M▼ 58.2% | -16.86M▼ 115.0% | -3.46M▲ 79.5% | -20.88M▲ 0% |
Operating Margin % | 1.36% | -1.58% | -1.91% | -1.1% | 8.31% | 9.63% | 5.58% | -1.25% | -0.33% | -2.08% |
Operating Income Growth % | 89.97% | -209.64% | -21.98% | 41.7% | 1620.79% | 93.73% | -58.24% | -114.96% | 79.47% | - |
EBITDA | 21.92M | -1.1M | -4.54M | 411K | 148.76M | 282.46M | 131.06M | 635K | 13.33M | -5.19M |
EBITDA Margin % | 2.53% | -0.13% | -0.55% | 0.05% | 8.87% | 10.08% | 6.49% | 0.05% | 1.26% | -0.52% |
EBITDA Growth % | 42.67% | -105.02% | -312.36% | 109.06% | 36093.67% | 89.88% | -53.6% | -99.52% | 1999.53% | -65.75% |
D&A (Non-Cash Add-back) | 10.17M | 11.78M | 11.18M | 9.57M | 9.45M | 12.58M | 18.35M | 17.5M | 16.79M | 15.69M |
EBIT | 8.52M | -12.54M | 8.87M | 16.32M | 145.1M | 267.49M | 110.99M | -725K | -3.46M | -82.89M |
Net Interest Income | -4.21M | -5.65M | -5.31M | -2.89M | -6.87M | -14.38M | -8.09M | -138K | 913K | 1.18M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 10K | 0 | 2.05M | 3.13M | 3.42M |
Interest Expense | 4.21M | 5.65M | 5.31M | 2.89M | 6.87M | 14.39M | 8.09M | 2.19M | 2.22M | 2.24M |
Other Income/Expense | -7.45M | -5.32M | -8.5M | -3.17M | -6.1M | -16.78M | -9.82M | 467K | -80.05M | -65.46M |
Pretax Income | 4.3M▲ 0% | -18.2M▼ 523.0% | -24.21M▼ 33.1% | -12.33M▲ 49.1% | 133.21M▲ 1180.4% | 253.1M▲ 90.0% | 102.89M▼ 59.3% | -16.4M▼ 115.9% | -83.51M▼ 409.3% | -86.34M▲ 0% |
Pretax Margin % | 0.5% | -2.23% | -2.94% | -1.47% | 7.94% | 9.03% | 5.09% | -1.22% | -7.92% | -8.62% |
Income Tax | -34.5M | -2.48M | 31.73M | -188K | 1.21M | 67.11M | 30.26M | -1.84M | 11.34M | 12.28M |
Effective Tax Rate % | -802.16% | 13.62% | -131.06% | 1.52% | 0.91% | 26.52% | 29.41% | 11.23% | -13.58% | -14.23% |
Net Income | 37.51M▲ 0% | -16.95M▼ 145.2% | -57.71M▼ 240.5% | -12.96M▲ 77.5% | 132M▲ 1118.4% | 185.98M▲ 40.9% | 72.63M▼ 60.9% | -14.56M▼ 120.0% | -94.85M▼ 551.6% | -98.63M▲ 0% |
Net Margin % | 4.34% | -2.08% | -7.02% | -1.55% | 7.87% | 6.63% | 3.6% | -1.08% | -9% | -9.84% |
Net Income Growth % | 370.85% | -145.19% | -240.47% | 77.54% | 1118.38% | 40.89% | -60.95% | -120.04% | -551.64% | -456.03% |
Net Income (Continuing) | 38.8M | -15.72M | -55.94M | -12.14M | 132M | 185.98M | 72.63M | -14.56M | -94.85M | -98.63M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 630K | 670K | 868K | 534K | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 1.01▲ 0% | -0.48▼ 147.5% | -1.56▼ 225.0% | -0.34▲ 78.2% | 3.53▲ 1138.2% | 5.02▲ 42.2% | 2.05▼ 59.2% | -0.44▼ 121.5% | -2.93▼ 565.9% | -3.13▲ 0% |
EPS Growth % | 573.33% | -147.52% | -225% | 78.21% | 1138.24% | 42.21% | -59.16% | -121.46% | -565.91% | -472.55% |
EPS (Basic) | 1.07 | -0.48 | -1.56 | -0.34 | 3.60 | 5.09 | 2.07 | -0.44 | -2.93 | - |
Diluted Shares Outstanding | 36.17M | 35.66M | 35.81M | 36.09M | 37.39M | 37.54M | 35.48M | 33.38M | 32.41M | 31.47M |
Basic Shares Outstanding | 35.02M | 35.31M | 35.81M | 36.09M | 36.69M | 37.01M | 35.16M | 33.38M | 32.41M | 31.47M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
CCRN Balance Sheet
Cross Country Healthcare, Inc. (CCRN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 208.89M | 194.91M | 183.36M | 183.11M | 508.27M | 675.67M | 415.15M | 335M | 293.59M | 298.3M |
Cash & Short-Term Investments | 25.54M | 16.02M | 1.03M | 1.6M | 1.04M | 3.6M | 17.09M | 81.63M | 108.74M | 105.58M |
Cash Only | 25.54M | 16.02M | 1.03M | 1.6M | 1.04M | 3.6M | 17.09M | 81.63M | 108.74M | 105.58M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 177.1M | 170.31M | 174.54M | 174.7M | 498.95M | 659.96M | 388.35M | 242.88M | 167.51M | 184.05M |
Days Sales Outstanding | 74.73 | 76.14 | 77.48 | 76.24 | 108.62 | 85.93 | 70.18 | 65.96 | 57.99 | 69.18 |
Inventory | 5.29M | 6.21M | 0 | 0 | 0 | 11.07M | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | 3.03 | 3.73 | - | - | - | 1.85 | - | - | - | - |
Other Current Assets | 963K | 2.36M | 1.69M | 1.35M | 638K | 1.04M | 2.03M | 2.64M | 17.34M | 1.26M |
Total Non-Current Assets | 258.8M | 232.1M | 199.02M | 173.86M | 224.54M | 272.17M | 264.16M | 254.25M | 155.36M | 152.77M |
Property, Plant & Equipment | 14.09M | 13.63M | 28.94M | 22.9M | 23.38M | 22.92M | 29.94M | 31.32M | 29.98M | 29.09M |
Fixed Asset Turnover | 61.41x | 59.91x | 28.41x | 36.52x | 71.72x | 122.33x | 67.46x | 42.91x | 35.17x | 33.56x |
Goodwill | 117.59M | 101.06M | 101.07M | 90.92M | 119.49M | 163.27M | 135.43M | 135.06M | 63.8M | 63.8M |
Intangible Assets | 87.68M | 75.58M | 50.86M | 40.73M | 48.24M | 44.72M | 54.47M | 42.19M | 27.64M | 40.91M |
Long-Term Investments | 17.2M | 16.19M | 0 | 0 | 14.67M | 23.78M | 33K | 0 | 14.86M | 60.25M |
Other Non-Current Assets | 2.03M | 1.89M | 18.15M | 19.31M | 7.23M | 10.38M | 38.34M | 37.58M | 19.08M | 1.76M |
Total Assets | 467.69M▲ 0% | 427M▼ 8.7% | 382.37M▼ 10.5% | 356.97M▼ 6.6% | 732.81M▲ 105.3% | 947.84M▲ 29.3% | 679.32M▼ 28.3% | 589.25M▼ 13.3% | 448.95M▼ 23.8% | 451.07M▲ 0% |
Asset Turnover | 1.85x | 1.91x | 2.15x | 2.34x | 2.29x | 2.96x | 2.97x | 2.28x | 2.35x | 2.01x |
Asset Growth % | 20.42% | -8.7% | -10.45% | -6.64% | 105.28% | 29.34% | -28.33% | -13.26% | -23.81% | -63.58% |
Total Current Liabilities | 94.59M | 85.39M | 85.47M | 93.42M | 199.77M | 271.64M | 148.59M | 120.4M | 77.76M | 90.57M |
Accounts Payable | 50.6M | 43.74M | 45.73M | 49.88M | 109.75M | 12.86M | 3.04M | 5.74M | 46.03M | 47.6M |
Days Payables Outstanding | 29.02 | 26.31 | 27 | 28.73 | 30.78 | 2.15 | 0.71 | 1.96 | 19.59 | 21.01 |
Short-Term Debt | 6.88M | 5.24M | 0 | 2.42M | 8.27M | 0 | 0 | 0 | 1.16M | 974K |
Deferred Revenue (Current) | 34.27M | 33.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2.85M | 3.08M | 14.38M | 12.66M | 8.86M | 154.98M | 127M | 28.76M | 30.56M | 2.47M |
Current Ratio | 2.21x | 2.28x | 2.15x | 1.96x | 2.54x | 2.49x | 2.79x | 2.78x | 3.78x | 3.29x |
Quick Ratio | 2.15x | 2.21x | 2.15x | 1.96x | 2.54x | 2.45x | 2.79x | 2.78x | 3.78x | 3.29x |
Cash Conversion Cycle | 48.74 | 53.56 | - | - | - | 85.63 | - | - | - | 48.17 |
Total Non-Current Liabilities | 135.38M | 123.42M | 133.41M | 108.64M | 235.51M | 218.98M | 57.34M | 49.89M | 48.37M | 47.7M |
Long-Term Debt | 92.26M | 77.94M | 70.97M | 55.83M | 176.37M | 148.74M | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 19.07M | 15.23M | 10.85M | 4.88M | 2.66M | 1.78M | 1.16M | 5.04M |
Deferred Tax Liabilities | 105K | 95K | 7.52M | 6.59M | 190K | 247K | 401K | 566K | 2.52M | 5.22M |
Other Non-Current Liabilities | 43.02M | 45.38M | 35.84M | 30.98M | 48.1M | 65.12M | 54.27M | 47.54M | 44.7M | 43.93M |
Total Liabilities | 229.97M | 208.81M | 218.87M | 202.06M | 435.28M | 490.62M | 205.92M | 170.29M | 126.13M | 138.27M |
Total Debt | 99.13M | 83.18M | 94.92M | 78M | 195.49M | 157.75M | 5.27M | 3.87M | 2.32M | 2.04M |
Net Debt | 73.6M | 67.16M | 93.89M | 76.4M | 194.45M | 154.14M | -11.83M | -77.76M | -106.42M | -103.54M |
Debt / Equity | 0.42x | 0.38x | 0.58x | 0.50x | 0.66x | 0.35x | 0.01x | 0.01x | 0.01x | 0.01x |
Debt / EBITDA | 4.52x | - | - | 189.79x | 1.31x | 0.56x | 0.04x | 6.10x | 0.17x | -0.39x |
Net Debt / EBITDA | 3.36x | - | - | 185.89x | 1.31x | 0.55x | -0.09x | -122.46x | -7.98x | 19.94x |
Interest Coverage | 2.02x | -2.22x | 1.67x | 5.65x | 21.13x | 18.59x | 13.71x | -0.33x | -1.56x | -37.00x |
Total Equity | 237.72M▲ 0% | 218.2M▼ 8.2% | 163.5M▼ 25.1% | 154.91M▼ 5.3% | 297.53M▲ 92.1% | 457.22M▲ 53.7% | 473.39M▲ 3.5% | 418.96M▼ 11.5% | 322.82M▼ 22.9% | 312.81M▲ 0% |
Equity Growth % | 56.6% | -8.21% | -25.07% | -5.25% | 92.07% | 53.67% | 3.54% | -11.5% | -22.95% | -58.16% |
Book Value per Share | 6.57 | 6.12 | 4.57 | 4.29 | 7.96 | 12.18 | 13.34 | 12.55 | 9.96 | 9.94 |
Total Shareholders' Equity | 237.09M | 217.53M | 162.63M | 154.38M | 297.53M | 457.22M | 473.39M | 418.96M | 322.82M | 312.81M |
Common Stock | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 3K | 3K | 3K |
Retained Earnings | -67.11M | -84.06M | -141.78M | -154.74M | -22.73M | 165.73M | 238.36M | 218.06M | 123.21M | 118.94M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -1.17M | -1.46M | -1.24M | -1.28M | -1.29M | -1.39M | -1.39M | -1.44M | -1.56M | -1.69M |
Minority Interest | 630K | 670K | 868K | 534K | 0 | 0 | 0 | 0 | 0 | 0 |
CCRN Cash Flow Statement
Cross Country Healthcare, Inc. (CCRN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 45.51M | 21M | 5.54M | 27.2M | -85.62M | 134.05M | 248.5M | 120.12M | 48.25M | 47.34M |
Operating CF Margin % | 5.26% | 2.57% | 0.67% | 3.25% | -5.11% | 4.78% | 12.3% | 8.94% | 4.58% | - |
Operating CF Growth % | 50.96% | -53.86% | -73.61% | 390.87% | -414.73% | 256.57% | 85.38% | -51.66% | -59.83% | 33.55% |
Net Income | 38.8M | -15.72M | -55.94M | -12.14M | 132M | 185.98M | 72.63M | -14.56M | 0 | -98.63M |
Depreciation & Amortization | 10.17M | 11.78M | 14.07M | 12.67M | 9.85M | 12.58M | 18.35M | 18.2M | 0 | 8.19M |
Stock-Based Compensation | 4.08M | 3.58M | 3.4M | 5.4M | 6.89M | 7.39M | 6.58M | 6.03M | 0 | 1.64M |
Deferred Taxes | -33.81M | -3.41M | 31.16M | -932K | -9.93M | 5.11M | 1.3M | -1.94M | 0 | -617K |
Other Non-Cash Items | 23.17M | 32.16M | 27.03M | 25.05M | 12.82M | 26.7M | 22.16M | 24.77M | 17.79M | 16.16M |
Working Capital Changes | 3.1M | -7.39M | -14.17M | -2.85M | -237.26M | -103.71M | 127.48M | 87.63M | 30.46M | 33.4M |
Change in Receivables | 9.71M | 2.82M | -6.64M | -4.75M | -318.42M | -153.23M | 251.43M | 128.33M | 56.73M | 44.1M |
Change in Inventory | 1.82M | 7.09M | 1.31M | -7.24M | -83.29M | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -9.28M | -7.09M | -1.31M | 7.24M | 83.29M | 0 | -126.61M | -29.75M | -34.57M | 919K |
Cash from Investing | -91.38M | -6.68M | -2.94M | -4.62M | -34.05M | -43.87M | -13.78M | -8.71M | -8.16M | -7.73M |
Capital Expenditures | -5.11M | -4.6M | -2.94M | -4.62M | -7.17M | -8.79M | -13.97M | -8.71M | -8.16M | -7.73M |
CapEx % of Revenue | 0.59% | 0.56% | 0.36% | 0.55% | 0.43% | 0.31% | 0.69% | 0.65% | 0.77% | 0.77% |
Acquisitions | -86.27M | -2.08M | -1.57M | -1.15M | -26.88M | -35.09M | 199K | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -292K | -151K | 1.57M | 1.15M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 50.76M | -23.77M | -17.6M | -22.01M | 119.09M | -87.6M | -221.24M | -46.85M | -13.01M | -14.74M |
Debt Issued (Net) | 55.5M | -16.12M | -14.96M | -20.07M | 127.68M | 32.34M | -150.68M | 0 | 0 | 0 |
Equity Issued (Net) | 0 | -5M | -801K | -658K | -2.23M | -35.28M | -57.65M | -37.31M | -6.83M | -12.39M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -1.77M | -5M | -801K | -658K | -2.23M | -35.28M | -57.65M | -37.31M | -6.83M | -12.39M |
Other Financing | -4.74M | -2.64M | -1.84M | -1.28M | -6.35M | -84.65M | -12.91M | -9.54M | -6.17M | -2.35M |
Net Change in Cash | 4.91M▲ 0% | -9.52M▼ 294.0% | -14.99M▼ 57.5% | 568K▲ 103.8% | -564K▼ 199.3% | 2.57M▲ 555.3% | 13.49M▲ 425.3% | 64.54M▲ 378.4% | 27.11M▼ 58.0% | 24.89M▲ 0% |
Free Cash Flow | 40.4M▲ 0% | 16.4M▼ 59.4% | 2.6M▼ 84.1% | 22.59M▲ 768.1% | -92.79M▼ 510.8% | 125.26M▲ 235.0% | 234.52M▲ 87.2% | 111.4M▼ 52.5% | 40.09M▼ 64.0% | 39.6M▲ 0% |
FCF Margin % | 4.67% | 2.01% | 0.32% | 2.7% | -5.53% | 4.47% | 11.61% | 8.29% | 3.8% | 3.95% |
FCF Growth % | 71.01% | -59.4% | -84.13% | 768.14% | -510.77% | 235% | 87.22% | -52.5% | -64.01% | -64.45% |
FCF per Share | 1.12 | 0.46 | 0.07 | 0.63 | -2.48 | 3.34 | 6.61 | 3.34 | 1.24 | 1.26 |
FCF Conversion (FCF/Net Income) | 1.21x | -1.24x | -0.10x | -2.10x | -0.65x | 0.72x | 3.42x | -8.25x | -0.51x | -0.40x |
Interest Paid | 3.41M | 6.34M | 4.55M | 2.67M | 5.77M | 12.86M | 7.53M | 0 | 0 | 0 |
Taxes Paid | 697K | 1.04M | 555K | 612K | 3.61M | 82.89M | 21.99M | 2.43M | 0 | 0 |
CCRN Key Ratios
Cross Country Healthcare, Inc. (CCRN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 19.26% | -7.44% | -30.24% | -8.14% | 58.35% | 49.28% | 15.61% | -3.26% | -25.57% | -27.1% |
Return on Invested Capital (ROIC) | 3.33% | -3.24% | -4.34% | -2.81% | 28.89% | 36.69% | 15.76% | -3.15% | -0.93% | -5.85% |
Gross Margin | 26.42% | 25.67% | 24.81% | 24.24% | 22.37% | 22.28% | 22.3% | 20.41% | 18.66% | 19.84% |
Net Margin | 4.34% | -2.08% | -7.02% | -1.55% | 7.87% | 6.63% | 3.6% | -1.08% | -9% | -9.84% |
Debt / Equity | 0.42x | 0.38x | 0.58x | 0.50x | 0.66x | 0.35x | 0.01x | 0.01x | 0.01x | 0.01x |
Interest Coverage | 2.02x | -2.22x | 1.67x | 5.65x | 21.13x | 18.59x | 13.71x | -0.33x | -1.56x | -37.00x |
FCF Conversion | 1.21x | -1.24x | -0.10x | -2.10x | -0.65x | 0.72x | 3.42x | -8.25x | -0.51x | -0.40x |
Revenue Growth | 3.78% | -5.61% | 0.7% | 1.73% | 100.46% | 67.2% | -27.95% | -33.46% | -21.56% | -20.37% |
Related:CCRN Dividend History·CCRN Revenue History·CCRN Price History·CCRN P/E History·CCRN Financial Ratios·CCRN Institutional Holders
CCRN SEC Filings & Documents
Cross Country Healthcare, Inc. (CCRN) SEC filings — annual & quarterly reports (10-K, 10-Q)
CCRN Frequently Asked Questions
Cross Country Healthcare, Inc. (CCRN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cross Country Healthcare, Inc. (CCRN) reported $1.00B in revenue for fiscal year 2025. This represents a 417% increase from $193.8M in 1999.
Cross Country Healthcare, Inc. (CCRN) saw revenue decline by 21.6% over the past year.
Cross Country Healthcare, Inc. (CCRN) reported a net loss of $98.6M for fiscal year 2025.
Dividend & Returns
Cross Country Healthcare, Inc. (CCRN) has a return on equity (ROE) of -25.6%. Negative ROE indicates the company is unprofitable.
Cross Country Healthcare, Inc. (CCRN) generated $39.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.